JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB218606

Torin 1, mTOR inhibitor

Be the first to review this product! Submit a review

|

(3 Publications)

MW 607.6 Da, Purity >98%. Potent, selective, ATP-competitive mTOR inhibitor that directly inhibits both mTORC1 and mTORC2 complexes, with IC50 values between 2 and 10 nM in in vitro kinase assays. Displays 1000-fold selectivity for mTOR over PI3K, 200-fold selectivity for mTOR over DNA-PK, ATM and hVps34, and exhibits 100-fold binding selectivity relative to 450 other protein kinases. Impairs cell growth and proliferation.

Key facts

CAS number

1222998-36-8

Purity

>98%

Form

Solid

form

Molecular weight

607.6 Da

Molecular formula

C<sub>3</sub><sub>5</sub>H<sub>2</sub><sub>8</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>

PubChem

49836027

Nature

Synthetic

Solubility

Soluble in DMSO to 3 mM

Biochemical name

Torin 1

Biological description

Potent, selective, ATP-competitive mTOR inhibitor that directly inhibits both mTORC1 and mTORC2 complexes, with IC50 values between 2 and 10 nM in in vitro kinase assays. Displays 1000-fold selectivity for mTOR over PI3K, 200-fold selectivity for mTOR over DNA-PK, ATM and hVps34, and exhibits 100-fold binding selectivity relative to 450 other protein kinases. Impairs cell growth and proliferation.

Canonical smiles

CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F

InChi

InChI=1S/C35H28F3N5O2/c1-2-32(44)42-15-13-41(14-16-42)31-11-9-26(19-28(31)35(36,37)38)43-33(45)12-8-24-20-40-30-10-7-22(18-27(30)34(24)43)25-17-23-5-3-4-6-29(23)39-21-25/h3-12,17-21H,2,13-16H2,1H3

InChiKey

AKCRNFFTGXBONI-UHFFFAOYSA-N

IUPAC Name

1-[4-(4-propanoylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-9-quinolin-3-ylbenzo[h][1,6]naphthyridin-2-one

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 2273 Torin 1. 2273-25 is the same size as the 25 mg size of ab218606.

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DNA-PKcs also known as DNA-dependent protein kinase catalytic subunit is a large serine/threonine protein kinase with a mass of approximately 469 kDa. It is mainly expressed in the nucleus of cells and is involved in DNA damage repair processes. Another key molecule mTOR (mechanistic target of rapamycin) a 289 kDa protein integrates signals for nutrient and energy status to control cell growth. PI 3 Kinase family members including PI 3 Kinase p110 delta PI 3 Kinase p85 alpha VPS34 (Class III PI3K) PI 3 Kinase catalytic subunit alpha/PIK3CA PI 3 Kinase Class 2A/Cpk and PI 3 Kinase catalytic subunit gamma/PI3K-gamma contribute to various cellular functions through lipid signaling within the cytoplasm and plasma membrane. PI4 kinase beta (PI4KB) facilitates phosphatidylinositol 4-phosphate production relevant in multiple cell processes.
Biological function summary

DNA-PKcs plays a vital role in the non-homologous end joining (NHEJ) repair pathway essential for fixing DNA double-strand breaks. mTOR is a central regulator of cell metabolism growth proliferation and survival. PI 3 Kinase proteins through phosphorylation of inositol lipids on the cell membrane involve themselves in signal transduction pathways that regulate cell growth proliferation survival and differentiation. Some PI 3 Kinases such as p110 delta and VPS34 function within specific complexes like the phosphatidylinositol 3-kinase complex I. CDC42 binding protein kinase alpha (also known as MRCK alpha) influences cytoskeletal dynamics and cell motility by interacting with small GTPase CDC42.

Pathways

These targets participate in key pathways such as the PI3K-AKT-mTOR signaling pathway and the DNA damage response (DDR) pathway. The PI3K-AKT-mTOR pathway featuring proteins like mTOR and PI 3 Kinase catalytic subunits is important for regulating cell growth and metabolism. In the DDR pathway DNA-PKcs and related proteins like ATM (ataxia-telangiectasia mutated) and ATR (ATM and Rad3-related) help in recognizing and repairing DNA damages. These pathways ensure cellular responses to external and internal stimuli maintaining cellular homeostasis and genomic integrity.

Dysregulation in these proteins links to conditions like cancer and diabetes. For instance mutations in PI 3 Kinase catalytic subunit alpha (PIK3CA) frequently occur in various cancers affecting cell proliferation and survival. Abnormal mTOR signaling is associated with metabolic disorders including type 2 diabetes due to its role in insulin signaling pathways. Furthermore DNA repair defects involving DNA-PKcs could contribute to the development of cancer particularly in combination with mutations in other DDR-related proteins such as BRCA1/2. These relations in pathways highlight the importance of these proteins in disease progression and therapeutic targeting.

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Cell 187:6566-6583.e22 PubMed39332412

2024

mTOR activity paces human blastocyst stage developmental progression.

Applications

Unspecified application

Species

Unspecified reactive species

Dhanur P Iyer,Heidar Heidari Khoei,Vera A van der Weijden,Harunobu Kagawa,Saurabh J Pradhan,Maria Novatchkova,Afshan McCarthy,Teresa Rayon,Claire S Simon,Ilona Dunkel,Sissy E Wamaitha,Kay Elder,Phil Snell,Leila Christie,Edda G Schulz,Kathy K Niakan,Nicolas Rivron,Aydan Bulut-Karslioğlu

Development (Cambridge, England) 149: PubMed35299238

2022

Coordinated activities of Myosin Vb isoforms and mTOR signaling regulate epithelial cell morphology during development.

Applications

Unspecified application

Species

Unspecified reactive species

Kirti Gupta,Sudipta Mukherjee,Sumit Sen,Mahendra Sonawane

NPJ Regenerative medicine 6:68 PubMed34686684

2021

Analysis of the early response to spinal cord injury identified a key role for mTORC1 signaling in the activation of neural stem progenitor cells.

Applications

Unspecified application

Species

Unspecified reactive species

Johany Peñailillo,Miriam Palacios,Constanza Mounieres,Rosana Muñoz,Paula G Slater,Elena De Domenico,Ilya Patrushev,Mike Gilchrist,Juan Larraín
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com